A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

dc.contributor.author	Valladares Ayerbes, Manuel
dc.date.accessioned	2017-06-07T07:09:12Z
dc.date.available	2017-06-07T07:09:12Z
dc.date.issued	2011
dc.identifier.issn	0167-6997
dc.identifier.uri	http://hdl.handle.net/20.500.11940/3174
dc.language.iso	eng
dc.title	A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
dc.type	Artigo	es
dc.authorsophos	Viéitez, J. M.
dc.authorsophos	Valladares, M.
dc.authorsophos	Peláez, I.
dc.authorsophos	De Sande González, L.
dc.authorsophos	García-Foncillas, J.
dc.authorsophos	García-López, J. L.
dc.authorsophos	García-Girón, C.
dc.authorsophos	Reboredo, M.
dc.authorsophos	Bovio, H.
dc.authorsophos	Lacave, A. J.
dc.identifier.doi	10.1007/s10637-010-9400-z
dc.identifier.isi	294223500035
dc.identifier.sophos	9457
dc.issue.number	5
dc.journal.title	INVESTIGATIONAL NEW DRUGS
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	1038
dc.page.final	1044
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	29

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.